IS8390A - Use of gaboxadol in the treatment of insomnia - Google Patents

Use of gaboxadol in the treatment of insomnia

Info

Publication number: IS8390A
Authority: IS; Iceland
Prior art keywords: gaboxadol; insomnia; treatment
Prior art date: 2003-12-18

Application number

IS8390A

Other languages

Icelandic (is)

Inventor

Ebert Bjarke

Lundahl Jonas

Original Assignee

H. Lundbeck A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-18

Filing date

2006-03-30

Publication date

2006-03-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684447&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8390(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-03-30 Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S

2006-03-30 Publication of IS8390A publication Critical patent/IS8390A/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives

IS8390A 2003-12-18 2006-03-30 Use of gaboxadol in the treatment of insomnia IS8390A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200301877		2003-12-18
PCT/DK2004/000861 WO2005058313A1 (en)	2003-12-18	2004-12-14	Use of gaboxadol for treating insomnia

Publications (1)

Publication Number	Publication Date
IS8390A true IS8390A (en)	2006-03-30

Family

ID=34684447

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS8390A IS8390A (en)	2003-12-18	2006-03-30	Use of gaboxadol in the treatment of insomnia

Country Status (17)

Country	Link
EP (1)	EP1720547A1 (en)
JP (1)	JP2007515415A (en)
KR (1)	KR20060103335A (en)
CN (1)	CN1893942A (en)
AR (1)	AR047154A1 (en)
AU (1)	AU2004298313A1 (en)
BR (1)	BRPI0415893A (en)
CA (1)	CA2550610A1 (en)
EA (1)	EA200600989A1 (en)
IL (1)	IL176239A0 (en)
IS (1)	IS8390A (en)
MX (1)	MXPA06006685A (en)
NO (1)	NO20063320L (en)
SG (1)	SG133601A1 (en)
TW (1)	TW200528098A (en)
WO (1)	WO2005058313A1 (en)
ZA (1)	ZA200602762B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0402118D0 (en)	2004-01-30	2004-03-03	Merck Sharp & Dohme	Polymorphic forms of a GABAA agonist
EP1906953A4 (en) *	2005-04-29	2009-05-20	Lundbeck & Co As H	Acid and base salt forms of gaboxadol
US20190076409A1 (en) *	2017-09-12	2019-03-14	Ovid Therapeutics Inc.	Use of gaboxadol in the treatment of narcolepsy
CA3113644A1 (en)	2018-09-20	2020-03-26	Ovid Therapeutics Inc.	Use of gaboxadol for the treatment of tourette syndrome, tics and stuttering
JP2022514275A (en) *	2018-12-17	2022-02-10	オービッド・セラピューティクス・インコーポレイテッド	Use of gaboxador for the treatment of non-24-hour sleep-wake disorders
CN114786669A (en)	2019-12-18	2022-07-22	奥维德医疗公司	Gaboxadol for the therapeutic treatment of 1p36 deficiency syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19525598C2 (en) *	1995-07-13	1997-09-25	Max Planck Gesellschaft	sleeping pills
US20040157876A1 (en) *	2001-05-21	2004-08-12	Elema Michiel O	Granular preparations of gaboxadol

2004
- 2004-12-07 TW TW093137759A patent/TW200528098A/en unknown
- 2004-12-14 MX MXPA06006685A patent/MXPA06006685A/en unknown
- 2004-12-14 BR BRPI0415893-8A patent/BRPI0415893A/en not_active IP Right Cessation
- 2004-12-14 EP EP04803014A patent/EP1720547A1/en not_active Withdrawn
- 2004-12-14 EA EA200600989A patent/EA200600989A1/en unknown
- 2004-12-14 CA CA002550610A patent/CA2550610A1/en not_active Abandoned
- 2004-12-14 AU AU2004298313A patent/AU2004298313A1/en not_active Abandoned
- 2004-12-14 CN CNA2004800372437A patent/CN1893942A/en active Pending
- 2004-12-14 ZA ZA200602762A patent/ZA200602762B/en unknown
- 2004-12-14 KR KR1020067011921A patent/KR20060103335A/en not_active Application Discontinuation
- 2004-12-14 WO PCT/DK2004/000861 patent/WO2005058313A1/en active Application Filing
- 2004-12-14 JP JP2006544213A patent/JP2007515415A/en not_active Withdrawn
- 2004-12-14 SG SG200704528-9A patent/SG133601A1/en unknown
- 2004-12-17 AR ARP040104752A patent/AR047154A1/en not_active Application Discontinuation
2006
- 2006-03-30 IS IS8390A patent/IS8390A/en unknown
- 2006-06-11 IL IL176239A patent/IL176239A0/en unknown
- 2006-07-18 NO NO20063320A patent/NO20063320L/en unknown

Also Published As

Publication number	Publication date
BRPI0415893A (en)	2007-01-09
AU2004298313A1 (en)	2005-06-30
EP1720547A1 (en)	2006-11-15
EA200600989A1 (en)	2006-10-27
MXPA06006685A (en)	2006-08-23
AR047154A1 (en)	2006-01-11
ZA200602762B (en)	2007-06-27
NO20063320L (en)	2006-07-18
IL176239A0 (en)	2006-10-05
KR20060103335A (en)	2006-09-28
SG133601A1 (en)	2007-07-30
CA2550610A1 (en)	2005-06-30
CN1893942A (en)	2007-01-10
JP2007515415A (en)	2007-06-14
TW200528098A (en)	2005-09-01
WO2005058313A1 (en)	2005-06-30

Similar Documents

Publication	Publication Date	Title
IL172316A0 (en)	2011-08-01	Novel compounds and their use in therapy
DK1636139T3 (en)	2009-11-23	Water Treatment Facilities
IL178012A0 (en)	2006-12-31	Diphenyl-indol-2-on compounds and their use in the treatment of cancer
DE60319810D1 (en)	2008-04-30	ANSCHWEMMFILTERMEDIEN AND MANUFACTURING AND USE PROCESS
DE60315135D1 (en)	2007-09-06	therapy probe
IL180078A (en)	2014-01-30	9-cis-retinal derivative for use in the treatment of 11-cis -retinal deficiency
EE05505B1 (en)	2012-02-15	Personal therapy section
GB0324761D0 (en)	2003-11-26	Use of compounds in therapy
IS7348A (en)	2004-07-08	N-pyrazinyl-phenylsulfonamide and their use in the treatment of cerebrovascular diseases
DE602004010856D1 (en)	2008-02-07	Well treatment fluids
DK1678085T3 (en)	2010-08-23	Fluid treatment
IS7825A (en)	2005-04-26	Therapeutic treatment
NO20050689L (en)	2005-03-21	Therapeutic use
IS7444A (en)	2004-09-13	Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
IS8390A (en)	2006-03-30	Use of gaboxadol in the treatment of insomnia
DK1670482T4 (en)	2022-08-22	USE OF CICLESONIDE IN THE TREATMENT OF RESPIRATORY DISEASES
NO20055517D0 (en)	2005-11-22	4-, 6-O 7-hydroxyindoles with N-oxide groups and their use as therapeutic agents
ATA13602003A (en)	2005-04-15	THERAPEUTIC TREATMENT DEVICE
ITMI20030647A1 (en)	2004-10-02	DEVICE FOR THE TREATMENT OF BLOOD IN EXTRACORPOREA CIRCULATION
DE60329308D1 (en)	2009-10-29	SURFACE TREATMENT
IS7868A (en)	2005-05-26	Use of corticoliberin-urocortin system in the treatment of inflammatory diseases.
DK1496918T3 (en)	2023-05-15	USE OF SODIUM METHAARSENITE IN THE TREATMENT OF TUMORS
TWI365187B (en)	2012-06-01	7-azaindoles and the use thereof as therapeutic agents
IS8391A (en)	2006-03-30	Use of siramine in the treatment of cancer
DK1680405T3 (en)	2009-05-04	Bengamide derivatives and their use in the treatment of cancer diseases